Abstract
β-Mannosidosis results from a functional deficiency of the lysosomal enzyme, β-mannosidase. While being a well recognised, naturally occurring disease in both goats and cattle, it is an extremely rare disorder in humans with the first cases only being recorded in 1986. Until now the severity of the human disease has not mirrored that of its bovine or caprine counterparts, whose presentation is typically in the neonatal period with both altered skull morphology and seizures. Human β-mannosidosis has previously appeared to be a more indolent disease, with its only consistent phenotypic feature being developmental delay of varying severity. We report a patient, homozygous for a private mutation, who presented in the immediate perinatal period with seizures and who subsequently developed communicating hydrocephalus at 2 years of age.
These are two new phenotypic features for β-mannosidosis. The first being the neonatal onset of the seizures, for while seizures have been seen in 3 out of the previous 20 documented cases, they have never before manifested prior to 6 months of age. However, as in the previous documented cases, the seizures were difficult to control and were associated with severe developmental delay.
The second unique feature about this case was the development of communicating hydrocephalus. We discuss the possible mechanisms of its development.
In summary, β-mannosidosis must thus now be considered in the differential diagnosis of neonatal onset seizures, and the potential for the development of hydrocephalus should be monitored during subsequent clinical follow-up.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Competing interests: None declared
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abbitt B, Jones MZ, Kasari TR, Storts RW, Templeton JW, Holland PS, Castenson PE (1991) Beta-mannosidosis in twelve Salers calves. J Am Vet Med Assoc 198:109–113
Bedilu R, Nummy KA, Cooper A, Wevers R, Smeitink J, Kleijer WJ, Friderici KH (2002) Variable clinical presentation of lysosomal beta-mannosidosis in patients with null mutations. Mol Genet Metab 77:282–290
Cherian MP (2004) Beta-mannosidase deficiency in two mentally retarded girls with intractable seizures. Ann Saudi Med 24:393–395
Cooper A, Sardharwalla IB, Roberts MM (1986) Human beta-mannosidase deficiency. N Engl J Med 315:1231
Cooper A, Hatton C, Thornley M, Sardharwalla IB (1988) Human β-mannosidase deficiency: biochemical findings in plasma, fibroblasts, white cells and urine. J Inher Metab Dis 1:17–29
Cooper A, Wraith JE, Savage WJ, Thornley M, Noronha MJ (1991) Beta-mannosidase deficiency in a female infant with epileptic encephalopathy. J Inherit Metab Dis 14:18–22
Dorland L, Duran M, Hoefnagels FE et al (1988) Beta-mannosidosis in two brothers with hearing loss. J Inherit Metab Dis 11(Suppl 2): 255–258
Gort L, Duque J, Fabeiro JM, Zulaica A, Coll MJ, Chabás A (2006) Molecular analysis in two beta-mannosidosis patients: description of a new adult case. Mol Genet Metab 89:398–400
Jones MZ, Cunningham JG, Dade AW et al (1983) Caprine beta-mannosidosis: clinical and pathological features. J Neuropathol Exp Neurol 42:268–285
Jones MZ, Rathke EJ, Gage DA, Costello CE, Murakami K, Ohta M, Matsuura F (1992) Oligosaccharides accumulated in the bovine beta-mannosidosis kidney. J Inherit Metab Dis 15:57–67
Labauge P, Renard D, Castelnovo G, Sabourdy F, de Champfleur N, Levade T (2009) Beta-mannosidosis: a new cause of spinocerebellar ataxia. Clin Neurol Neurosurg 111:109–110
Manara R, Priante E, Grimaldi M et al (2011) Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy. J Inherit Metab Dis 34:763–780
Matheus MG, Castillo M, Smith JK, Armao D, Towle D, Muenzer J (2004) Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46:666–672
Poorthuis BJ, Wevers RA, Kleijer WJ et al (1999) The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105:151–156
Poupetova H, Ledvinova J, Berna L, Dvoráková L, Kozich V, Elleder M (2010) The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis 33:387–396
Thomas GH (2001) Disorders of glycoprotein degradation: a-mannosidosis, b-mannosidosis, fucosidosis, and sialidosis. In: Scriver CR, Beudet AL, Valle D et al (eds) The Metabolic and molcular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 3507–3535
Vedolin L, Schwartz IV, Komlos M et al (2007) Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology 69:917–924
Wenger DA, Sujansky E, Fennessey PV, Thompson JN (1986) Human beta-mannosidase deficiency. N Engl J Med 315:1201–1205
Wijburg H, de Jong J, Wevers R, Bakkeren J, Bakkeren J, Trijbels F, Sengers R (1992) Beta-mannosidosis and ethanolaminuria in a female patient. Eur J Pediatr 151:311
Zhu M, Lovell KL, Patterson JS, Saunders TL, Hughes ED, Friderici KH (2006) Beta-mannosidosis mice: a model for the human lysosomal storage disease. Hum Mol Genet 15:493–500
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Verena Peters
Rights and permissions
Copyright information
© 2013 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Broomfield, A., Gunny, R., Ali, I., Vellodi, A., Prabhakar, P. (2013). A Clinically Severe Variant of β-Mannosidosis, Presenting with Neonatal Onset Epilepsy with Subsequent Evolution of Hydrocephalus. In: Zschocke, J., Gibson, K., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports - Volume 11. JIMD Reports, vol 11. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2013_227
Download citation
DOI: https://doi.org/10.1007/8904_2013_227
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37327-5
Online ISBN: 978-3-642-37328-2
eBook Packages: MedicineMedicine (R0)